Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-4.65M
-
Total reported value, excl. options
-
$7.28B
-
Value change
-
-$290M
-
Put/Call ratio
-
1.31
-
Number of buys
-
160
-
Number of sells
-
-180
-
Price
-
$59.91
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2019
452 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2019.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 159M outstanding shares and own 76.73% of the company stock.
Largest 10 shareholders include FMR LLC (20.9M shares), VANGUARD GROUP INC (12.2M shares), Clearbridge Investments, LLC (9.29M shares), BAILLIE GIFFORD & CO (8.42M shares), BlackRock Inc. (8.35M shares), Bellevue Group AG (8.32M shares), WELLINGTON MANAGEMENT GROUP LLP (7.75M shares), STATE STREET CORP (3.65M shares), WADDELL & REED FINANCIAL INC (3.18M shares), and Invesco Ltd. (2.38M shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.